Edwards Lifesciences Corporation
Organization details
- Legal name
- Edwards Lifesciences Corporation
- Former names
- CVG Controlled Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Irvine
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- EW
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001099800
- EIN
- 36-4316614
- Wikidata ID
- Q16966841
Board of directors
-
Bernard J. Zovighian · Director · CEOSince 2022
-
David T. Feinberg · DirectorSince 2024
-
Heisz Leslie Stone · DirectorSince 2023
-
Kieran Gallahue · DirectorSince 2023
-
Leslie C. Davis · DirectorSince 2024
-
Martha H. Marsh · DirectorSince 2023
-
Michael A. Mussallem · Director · Chairman & CEOSince 2023
-
Nicholas J. Valeriani · DirectorSince 2023
-
Paul A. Laviolette · DirectorSince 2023
-
Ramona Sequeira · DirectorSince 2023
-
Steven R. Loranger · DirectorSince 2023
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 35% of the scoring weight is on file.
- Revenue growth 20%
- 57
- Earnings growth 15%
- 27
3.8% a year in revenue
-6.4% a year in earnings per share
35% of the scoring weight is on file. Figures cover December 2021 – December 2025.
Director election results
Annual meeting of May 7, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.4%
-
92.8%
-
93.9%
-
96.1%
-
96.6%
-
97.2%
-
99.6%
-
99.7%
Board connections
7 of this board's directors also sit on 9 other boards. 3 are in the same sector.
- via Martha H. Marsh
- via David T. Feinberg
-
Envista Holdings Corporation Same sectorvia Kieran Gallahue
- via David T. Feinberg
- via Heisz Leslie Stone
-
Organon & Co. Same sectorvia Ramona Sequeira
- via Heisz Leslie Stone
-
Pulse Biosciences Inc Same sectorvia Paul A. Laviolette
- via Steven R. Loranger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $34,056,044
- 55 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 2026 | Dahl Andrew M. Officer (SVP, Corporate Controller) | Shares withheld for tax | −101 | $105.80 | $10,686 |
| Nov 10, 2026 | Lippis Daniel J. Officer (CVP, TAVR) | Option exercise | +619 | $72.68 | $44,989 |
| Nov 10, 2026 | Lippis Daniel J. Officer (CVP, TAVR) | Open-market sale | −619 | $104.25 | $64,531 |
| Nov 9, 2026 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Option exercise | +48,900 | $72.68 | $3,554,052 |
| Nov 9, 2026 | Bernard J. Zovighian Director, Officer (CEO) | Option exercise | +23,100 | $72.68 | $1,678,908 |
| Nov 9, 2026 | BOBO DONALD E JR Officer (CVP,Strategy/Corp Development) | Open-market sale | −48,900 | $103.05 | $5,039,311 |
| Nov 9, 2026 | Bernard J. Zovighian Director, Officer (CEO) | Open-market sale | −9,184 | $103.39 | $949,489 |
| Nov 9, 2026 | Bernard J. Zovighian Director, Officer (CEO) | Open-market sale | −13,916 | $102.78 | $1,430,291 |
| Oct 8, 2026 | Lippis Daniel J. Officer (CVP, TAVR) | Option exercise | +619 | $72.68 | $44,989 |
| Oct 8, 2026 | Lippis Daniel J. Officer (CVP, TAVR) | Open-market sale | −619 | $85.65 | $53,017 |
| Sep 14, 2026 | Markowitz Wayne Officer (CVP, JAPAC) | Shares withheld for tax | −568 | $84.37 | $47,922 |
| Sep 13, 2026 | Dahl Andrew M. Officer (SVP, Corporate Controller) | Shares withheld for tax | −253 | $84.37 | $21,346 |
| Sep 11, 2026 | Chopra Daveen Officer (CVP, TMTT, Surgical & IHFM) | Shares withheld for tax | −398 | $86.77 | $34,534 |
| Sep 11, 2026 | Lippis Daniel J. Officer (CVP, TAVR) | Option exercise | +619 | $72.68 | $44,989 |
| Sep 11, 2026 | Markowitz Wayne Officer (CVP, JAPAC) | Shares withheld for tax | −355 | $86.77 | $30,803 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Edwards Lifesciences Corporation
Who is the CEO of Edwards Lifesciences Corporation?
Bernard J. Zovighian has been Edwards Lifesciences Corporation's CEO since May 2022.
How many directors are on Edwards Lifesciences Corporation's board?
Edwards Lifesciences Corporation's board has 11 directors: Bernard J. Zovighian, David T. Feinberg, Heisz Leslie Stone, Kieran Gallahue, Leslie C. Davis, Martha H. Marsh, Michael A. Mussallem, Nicholas J. Valeriani, Paul A. Laviolette, Ramona Sequeira and 1 other.
Are Edwards Lifesciences Corporation insiders buying or selling shares?
Over the last 12 months, Edwards Lifesciences Corporation insiders made no open-market purchases and sold $34.1 million of shares in 55 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="edwards-lifesciences-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.